Linking Pharmacovigilance with Pharmacogenetics
- 1 January 2004
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 27 (15) , 1171-1184
Abstract
The ability to identify individuals who are susceptible to adverse drug reactions (ADRs) has the potential to reduce the personal and population costs of drug-related morbidity. Some individuals may...Keywords
This publication has 73 references indexed in Scilit:
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- Do Some Inhibitors of COX-2 Increase the Risk of Thromboembolic Events?Drug Safety, 2004
- Influence of Age and Cytochrome P450 2C9 Genotype on the Steady-State Disposition of Diclofenac and CelecoxibClinical Pharmacokinetics, 2003
- Determination of ?2-adrenergic receptor (ADRB2) haplotypes by a multiplexed polymerase chain reaction assayHuman Mutation, 2002
- A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depressionThe Pharmacogenomics Journal, 2002
- Maximizing the value of medicines by including pharmacogenetic research in drug development and surveillanceBritish Journal of Clinical Pharmacology, 2002
- Genotyping of Drug TargetsDrug Safety, 2002
- Signal Generation in the New Zealand Intensive Medicines Monitoring ProgrammeDrug Safety, 2002
- Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complicationsThe Lancet, 1999
- Airway Subsensitivity with Long-Acting ??2-Agonists Is There Cause for Concern?Drug Safety, 1997